Sign Up Today and Learn More About ABK Biomedical Stock
Invest in or calculate the value of your shares in ABK Biomedical or other pre-IPO companies through EquityZen's platform.
ABK Biomedical Stock (ABBI)
ABK Biomedical combines the clinical market with biomaterials with a focus on treating hypervascular tumors.
About ABK Biomedical Stock
Founded
2012
Industries
Software, Artificial Intelligence, Data and Analytics
ABK Biomedical Press Mentions
Stay in the know about the latest news on ABK Biomedical
ABK Biomedical Announces FDA IDE Stage 2 Approval for Route90, a Prospective, Multi-Center, Pivotal Study of Eye90 microspheres® in unresectable Hepatocellular Cancer
prnewswire • Nov 19, 2024
Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Key Strategy Matrices ...
motionsonline • May 23, 2024
Delivery device
patents • Apr 13, 2024
Radiopaque glass material
patents • Apr 13, 2024
Composition of radioactive and non-radioactive microparticles
patents • Apr 13, 2024
ABK Biomedical Management
Leadership team at ABK Biomedical
Co-Founder
Daniel Boyd
President and CEO
Michael Mangano
Join now and verify your accreditation status to gain access to:
- ABK Biomedical current valuation
- ABK Biomedical stock price
- Available deals in ABK Biomedical and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading ABK Biomedical Stock
How to invest in ABK Biomedical stock?
Accredited investors can buy pre-IPO stock in companies like ABK Biomedical through EquityZen funds. These investments are made available by existing ABK Biomedical shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell ABK Biomedical stock?
Shareholders can sell their ABK Biomedical stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
